Teva Names Former Sandoz CEO Francis To Replace Schultz Within Weeks

Richard Francis Will Take Lead At Israeli Generics Giant From The Start Of 2023

 
• By Dave Wallace

In just under six weeks Teva will have a new president and CEO, after former Sandoz chief Richard Francis was announced as Kåre Schultz’s replacement from the start of 2023.

Francis_Richard
Richard Francis will replace Kåre Schultz as president and CEO of Teva

More from Leadership

More from Generics Bulletin